For early prostate cancer, 'active surveillance' is now the number 1 choice
Repercussão envolvendo San Francisco chama atenção em Fitness.
Notícias
Acompanhe as Notícias da Recifes
Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.
Half of prostate cancer focal therapy use found to fall outside current guideline-supported groups
Repercussão envolvendo fonte internacional chama atenção em Fitness.
SolarEdge options trade targets a rally to $50 by December 2026
Repercussão envolvendo fonte internacional chama atenção em Economia. Destaque: $50.
SMCI options activity: call volume surges as implied volatility hits 82.6%
SMCI options activity: call volume surges as implied volatility hits 82.6%. Destaque: 82.6%.
The main contenders to replace Rodri at Man City
Repercussão envolvendo Man City As, Manchester City chama atenção em Esportes.
Celtic sign midfielder Baur on an initial four-year deal
Repercussão envolvendo Mika Baur chama atenção em Esportes.
Meta adds AI screening to detect WhatsApp scams
Repercussão envolvendo Scam Alert chama atenção em Tech.
There's a new flu vaccine on the market. Will it move the needle on reducing disease?
Repercussão envolvendo Northern Hemisphere chama atenção em Fitness.
Gulf states scramble for Strait of Hormuz alternatives
Saudi Arabia has redirected oil exports away from the Strait of Hormuz, but most Gulf producers still lack a reliable backup option to the world's most important energy choke point.
The latest rally has energized the stock market but left the credit market concerned
Options traders are chipper about equities but wary of debt.
Failure not an option as Ange Postecoglou gears up for biggest challenge yet alongside Ronaldo | John Duerden
The Australian has become Al-Nassr’s 12th coach of the 2020s and while taking over a star-studded squad may seem a comfortable gig, it will be anything but in the Saudi Pro LeagueWhen Ange Postecoglou left Nottingham Forest in October, few would have predicted his next port of ca
Sugar swap simplifies production of promising targeted cancer therapies
Researchers at the University of Wisconsin–Madison have developed a simpler way to produce a fast-growing class of targeted cancer therapies, a discovery that could make the medicines easier to manufacture consistently while driving the development of new treatment options.